Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 8,105 | 7,255 | 5,935 | 6,253 | 5,651 |
| Operating Income | -8,105 | -7,255 | -5,935 | -6,253 | -5,651 |
| Other Income | -4,008 | -32,962 | 1,673 | 552 | -1,002 |
| Pre-tax Income | -12,113 | -40,217 | -4,262 | -5,701 | -6,653 |
| Net Income Continuous | -12,113 | -40,217 | -4,262 | -5,701 | -6,653 |
| Net Income | $-12,113 | $-40,217 | $-4,262 | $-5,701 | $-6,653 |
| EPS Basic Total Ops | -0.23 | -0.60 | -0.07 | -0.12 | -0.13 |
| EPS Basic Continuous Ops | -0.23 | -0.60 | -0.07 | -0.12 | -0.13 |
| EPS Diluted Total Ops | -0.23 | -0.60 | -0.07 | -0.12 | -0.13 |
| EPS Diluted Continuous Ops | -0.23 | -0.60 | -0.07 | -0.12 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.18 | -0.11 | -0.07 | N/A | N/A |
| EBITDA(a) | $-8,327 | $-7,758 | $-6,138 | $-6,381 | $-5,750 |